LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 78.91 | 17.25 | 9898 | 5730 | 1.7272 | 1.1349 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 80.88 | 17.25 | 1536 | 5826 | 0.2636 | 0.7065 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 80.88 | 17.25 | 9664 | 5826 | 1.6588 | 1.1242 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 80.88 | 17.25 | 448 | 5826 | 0.0769 | 0.4737 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 80.88 | 17.25 | 10184 | 5826 | 1.7480 | 1.1375 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.85 | 17.25 | 1391 | 5861 | 0.2373 | 0.6855 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.85 | 17.25 | 9842 | 5861 | 1.6791 | 1.1271 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.85 | 17.25 | 476 | 5861 | 0.0812 | 0.4837 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 82.85 | 17.25 | 10470 | 5861 | 1.7862 | 1.1428 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.82 | 17.25 | 1069 | 5924 | 0.1805 | 0.6321 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.82 | 17.25 | 10047 | 5924 | 1.6959 | 1.1294 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.82 | 17.25 | 452 | 5924 | 0.0763 | 0.4736 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 84.82 | 17.25 | 10787 | 5924 | 1.8209 | 1.1475 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.79 | 17.25 | 683 | 6008 | 0.1137 | 0.5460 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.79 | 17.25 | 10278 | 6008 | 1.7106 | 1.1313 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.79 | 17.25 | 333 | 6008 | 0.0554 | 0.4199 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 86.79 | 17.25 | 11146 | 6008 | 1.8551 | 1.1518 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.76 | 17.25 | 595 | 6047 | 0.0984 | 0.5202 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.76 | 17.25 | 10628 | 6047 | 1.7573 | 1.1379 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.76 | 17.25 | 298 | 6047 | 0.0493 | 0.4008 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 88.76 | 17.25 | 11419 | 6047 | 1.8881 | 1.1562 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.74 | 17.25 | 345 | 6109 | 0.0565 | 0.4244 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.74 | 17.25 | 10867 | 6109 | 1.7787 | 1.1407 | MN20160310_N02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.74 | 17.25 | 114 | 6109 | 0.0187 | 0.2498 | MN20160310_N02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 90.74 | 17.25 | 11783 | 6109 | 1.9286 | 1.1613 | MN20160310_N02 | D18 |